drug · small molecule
patient view →Anti-inflammatory
pre_registrationupdated 2mo agoby AimMax Therapeutics Inc🔗 ChEMBL
community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 11 investigational indications.
targets
Mitogen-activated protein kinase 11Mitogen-activated protein kinase 14
all catalysts(0)
nothing on the calendar yet
News(1)
- Sanofi posts upbeat sales as R&D pressure builds<figure><div><img src="https://imgproxy.divecdn.com/4sV6C1TzSj2YZ2rz0W5-EST8xmsio5JNKmZoYu-be_8/g:nowe:0:87/c:520:294/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
comments(0)
5-min edit window · permanent after that